Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance

Cancer statistics: Breast cancer in situ

(2015) Elizabeth M. Ward et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Programmed death-1 pathway in cancer and autoimmunity

(2014) Ariel Pedoeem et al.   CLINICAL IMMUNOLOGY

Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo

(2014) Michael Berger et al.   JOURNAL OF HEPATOLOGY

Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer

(2013) Yunli Zhou et al.   BREAST CANCER RESEARCH AND TREATMENT

Neurotransmitter Substance P Mediates Pancreatic Cancer Perineural Invasion via NK-1R in Cancer Cells

(2013) Xuqi Li et al.   MOLECULAR CANCER RESEARCH

Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents

(2012) F. Andre et al.   ANNALS OF ONCOLOGY

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

(2012) G. Curigliano et al.   ANNALS OF ONCOLOGY

Neoadjuvant treatments for triple-negative breast cancer (TNBC)

(2012) G. von Minckwitz et al.   ANNALS OF ONCOLOGY

FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair

(2012) Yun-Yong Park et al.   CARCINOGENESIS

Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood–brain barrier during extravasation and brain invasion

(2012) Kate M. Lewis et al.   CLINICAL & EXPERIMENTAL METASTASIS

Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease

(2012) Kai Chen et al.   Current Atherosclerosis Reports

Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons

(2012) Stefanie C. Huelsenbeck et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells

(2011) Giselle C. Meléndez et al.   CARDIOVASCULAR RESEARCH

Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells

(2011) Fan Feng et al.   CELL BIOLOGY INTERNATIONAL

The NK-1 Receptor: A New Target in Cancer Therapy

(2011) Miguel Munoz et al.   CURRENT DRUG TARGETS

Reactive oxygen species in cardiovascular disease

(2011) Koichi Sugamura et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials

(2010) Lesley A Smith et al.   BMC CANCER

A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists

(2010) M. Munoz et al.   CURRENT MEDICINAL CHEMISTRY

Induction of Nonapoptotic Cell Death by Activated Ras Requires Inverse Regulation of Rac1 and Arf6

(2010) Haymanti Bhanot et al.   MOLECULAR CANCER RESEARCH

The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras

(2009) Joo-Yun Byun et al.   CARCINOGENESIS

The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug

(2009) Miguel Muñoz et al.   INVESTIGATIONAL NEW DRUGS